Intra-Cellular Therapies
ITCI
#1807
Rank
S$12.14 B
Marketcap
$114.60
Share price
-2.70%
Change (1 day)
49.80%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Market cap: S$12.14 Billion

As of November 2024 Intra-Cellular Therapies has a market cap of S$12.14 Billion. This makes Intra-Cellular Therapies the world's 1807th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2024

End of year Market Cap

Year Marketcap Change
2024S$12.14 B33.47%
2023S$9.10 B35.49%
2022S$6.71 B16.56%
2021S$5.76 B70.29%
2020S$3.38 B31.84%
2019S$2.56 B200.58%
2018S$0.85 B-19.19%
2017S$1.05 B11.86%
2016S$0.94 B-71.22%
2015S$3.28 B377.29%
2014S$0.68 B22.52%
2013S$0.56 B

End of Day market cap according to different sources

On Nov 14th, 2024 the market cap of Intra-Cellular Therapies was reported to be:

S$12.48 Billion
by Nasdaq info icon info icon
S$12.48 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$0.12 B-98.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$29.37 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.14 B-82.36%๐Ÿ‡บ๐Ÿ‡ธ USA